<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutrients</journal-id><journal-id journal-id-type="iso-abbrev">Nutrients</journal-id><journal-id journal-id-type="publisher-id">nutrients</journal-id><journal-title-group><journal-title>Nutrients</journal-title></journal-title-group><issn pub-type="epub">2072-6643</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6213720</article-id><article-id pub-id-type="doi">10.3390/nu10101546</article-id><article-id pub-id-type="publisher-id">nutrients-10-01546</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>The Effects of Adjuvant Fermented Wheat Germ Extract on Cancer Cell Lines: A Systematic Review</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2153-0778</contrib-id><name><surname>Zhurakivska</surname><given-names>Khrystyna</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5647-4414</contrib-id><name><surname>Troiano</surname><given-names>Giuseppe</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5080-5921</contrib-id><name><surname>Caponio</surname><given-names>Vito Carlo Alberto</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dioguardi</surname><given-names>Mario</given-names></name></contrib><contrib contrib-type="author"><name><surname>Arena</surname><given-names>Claudia</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4633-4893</contrib-id><name><surname>Lo Muzio</surname><given-names>Lorenzo</given-names></name><xref rid="c1-nutrients-10-01546" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-nutrients-10-01546">Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy; <email>khrystyna.zhurakivska@unifg.it</email> (K.Z.); <email>giuseppe.troiano@unifg.it</email> (G.T.); <email>karlos_93@hotmail.it</email> (V.C.A.C.); <email>mario.dioguardi@unifg.it</email> (M.D.); <email>claudia.arena@unifg.it</email> (C.A.)</aff><author-notes><corresp id="c1-nutrients-10-01546"><label>*</label>Correspondence: <email>lorenzo.lomuzio@unifg.it</email>; Tel.: +39-0881-588090; Fax: +39-0881-588081</corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>10</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>10</month><year>2018</year></pub-date><volume>10</volume><issue>10</issue><elocation-id>1546</elocation-id><history><date date-type="received"><day>20</day><month>9</month><year>2018</year></date><date date-type="accepted"><day>15</day><month>10</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 by the authors.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Fermented wheat germ extract (FWGE; trade name AVEMAR) is a natural compound derived from industrial fermentation of wheat germ. Its potential anticancer properties has emerged from recent studies. The aim of this systematic review is to summarize the data available in the scientific literature concerning the in vitro activity of FWGE on malignant cells. A systematic review of English articles in electronic databases has been performed. The primary outcomes of the review regarded types of cancer cell lines subjected to the investigation and the main results concerning cell viability, proliferation, and apoptosis observed within the studies. Sixteen articles were included in the final qualitative analysis. Various types of cancer cells treated with FWGE have been analyzed, showing mainly cytotoxic effects, alteration of the cell cycle, antiproliferative effects, and induction of apoptosis. FWGE can be a promising drug component in cancer treatment; however, further in vitro and in vivo studies are necessary to prove its effectiveness and safety in humans.</p></abstract><kwd-group><kwd>FWGE</kwd><kwd>AVEMAR</kwd><kwd>fermented wheat germ extract</kwd><kwd>nutraceuticals</kwd><kwd>cancer treatment</kwd></kwd-group></article-meta></front><body><sec id="sec1-nutrients-10-01546"><title>1. Introduction</title><p>Recently, more and more attention has been placed on the use of nutraceuticals as therapeutic agents for cancer prevention, as well as supplements to conventional therapy because of their promising effects and a low rate of toxicity [<xref rid="B1-nutrients-10-01546" ref-type="bibr">1</xref>,<xref rid="B2-nutrients-10-01546" ref-type="bibr">2</xref>,<xref rid="B3-nutrients-10-01546" ref-type="bibr">3</xref>]. A number of natural compounds have been found to inhibit one or more pathways that contribute to proliferation of cancer cells and metastatic processes [<xref rid="B4-nutrients-10-01546" ref-type="bibr">4</xref>]. The most investigated and promising compounds studied in the last years include: curcumin [<xref rid="B5-nutrients-10-01546" ref-type="bibr">5</xref>], resveratrol [<xref rid="B6-nutrients-10-01546" ref-type="bibr">6</xref>], and indole-3-carbinol [<xref rid="B7-nutrients-10-01546" ref-type="bibr">7</xref>], which are naturally present in some species of fruit and vegetables.</p><p>Fermented wheat germ extract (FWGE; trade name AVEMAR) is a product of industrial fermentation of wheat germ. Its production process is patented and is derived from the extraction of wheat germ and fermentation by <italic>Saccharomyces cerevisiae</italic>, followed by separation of the fermentation liquid, drying, and then granulation. As with other nutraceuticals, FWGE contains various molecules, but recent studies assume that the two quinones, 2-methoxy benzoquinone and 2, 6-dimethoxy benzoquinone, which are present in wheat germ as glucosides, are likely to be responsible for some of the biological properties of FWGE [<xref rid="B8-nutrients-10-01546" ref-type="bibr">8</xref>,<xref rid="B9-nutrients-10-01546" ref-type="bibr">9</xref>].</p><p>Quinones are cyclic organic compounds containing two carbonyl groups (C=O) linked to the cyclic structure of a conjugated system. Several anticancer compounds, e.g., Mitomycin C, Mitotraxan, Doxorubicin, and Daunorubicin, are quinone derivatives [<xref rid="B10-nutrients-10-01546" ref-type="bibr">10</xref>,<xref rid="B11-nutrients-10-01546" ref-type="bibr">11</xref>]. The anticancer characteristics of AVEMAR have been deeply investigated, and results have suggested its metabolic, antiproliferative, and antimetastatic effects [<xref rid="B12-nutrients-10-01546" ref-type="bibr">12</xref>,<xref rid="B13-nutrients-10-01546" ref-type="bibr">13</xref>,<xref rid="B14-nutrients-10-01546" ref-type="bibr">14</xref>].</p><p>The antimetabolic effects of FWGE on cancer cells seems to be due to a hypermetabolic state of the cancer cells and their upregulated utilization of glucose [<xref rid="B15-nutrients-10-01546" ref-type="bibr">15</xref>,<xref rid="B16-nutrients-10-01546" ref-type="bibr">16</xref>]. The antimetastatic effect of FWGE, besides the immune-reconstitution, may also be due to its cell adhesion inhibitory, cell proliferation inhibitory, apoptosis enhancing, and antioxidant characteristics, which have also been observed in some in vitro experiments [<xref rid="B17-nutrients-10-01546" ref-type="bibr">17</xref>]. The antiproliferative action has been investigated in in vitro and in vivo studies performed on various human cancer cell lines and animal models, and results have shown a reduction of tumor growth in a dose-dependent manner [<xref rid="B8-nutrients-10-01546" ref-type="bibr">8</xref>,<xref rid="B17-nutrients-10-01546" ref-type="bibr">17</xref>,<xref rid="B18-nutrients-10-01546" ref-type="bibr">18</xref>,<xref rid="B19-nutrients-10-01546" ref-type="bibr">19</xref>].</p><p>The antimetastatic effect of FWGE investigated in vitro and in vivo by several studies appears to be promising for FWGE to be used alone or in association with traditional anticancer agents [<xref rid="B8-nutrients-10-01546" ref-type="bibr">8</xref>,<xref rid="B17-nutrients-10-01546" ref-type="bibr">17</xref>].</p><p>The aim of this systematic review is to summarize the data available in the scientific literature concerning the in vitro activity of FWGE on malignant cells.</p></sec><sec id="sec2-nutrients-10-01546"><title>2. Materials and Methods</title><p>This systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [<xref rid="B20-nutrients-10-01546" ref-type="bibr">20</xref>]. A systematic review of English articles in electronic databases (PubMed, Scopus, and Web of Science) was performed independently by two authors (KZ and GT) using search terms: (AVEMAR OR &#x0201c;wheat germ extract&#x0201d;) AND (cancer OR antitumoral OR anticancer). No restrictions were imposed on the study designs.</p><p>The criterion for inclusion in this systematic review was in vitro original studies on human tumor cell lines where the effects of FWGE have been evaluated. No restriction on publication dates was applied. No restriction of materials and methods was applied.</p><p>The exclusion criteria were letters to the editor, in vivo studies, and reviews. Articles and abstracts written in languages other than English were excluded.</p><p>A first selection was performed by reading the titles and the abstracts of the search results. After this round, duplicates resulting from the use of different databases were removed. The abstracts that seemed to meet the inclusion criteria were selected and the full texts were read. Once the full-text evaluation was performed, only studies meeting all inclusion criteria and considered eligible by both authors were included in the review. Disagreements between the authors were resolved through discussion.</p><p>Furthermore, the bibliographies of the included articles were examined in order to find other studies to include in this review.</p><p>The data concerning the type of the cells and the main evaluations performed on them were collected and the results are summarized in <xref rid="nutrients-10-01546-t001" ref-type="table">Table 1</xref>. No differentiation between methods was applied, and only the final results were considered.</p><p>The primary outcomes of the review regarded types of cancer cell lines subjected to the investigation and the main results concerning the cell viability, proliferation, and apoptosis observed in the studies. No quantification was made, but only significant results were considered and reported in the present review.</p><p>The secondary outcomes regarded other types of interventions and evaluations performed on the cells, their results in term of cellular metabolism, and enzymatic activity.</p></sec><sec id="sec3-nutrients-10-01546"><title>3. Results</title><p>A total of 56 titles and articles from PubMed, 53 from Scopus, and 52 from Web of Science were screened in the first round of the selection process. After duplicates were removed, 20 studies were identified as acceptable for full-text evaluation and their full texts were read. At the end of the selection process, 16 articles [<xref rid="B13-nutrients-10-01546" ref-type="bibr">13</xref>,<xref rid="B18-nutrients-10-01546" ref-type="bibr">18</xref>,<xref rid="B19-nutrients-10-01546" ref-type="bibr">19</xref>,<xref rid="B21-nutrients-10-01546" ref-type="bibr">21</xref>,<xref rid="B22-nutrients-10-01546" ref-type="bibr">22</xref>,<xref rid="B23-nutrients-10-01546" ref-type="bibr">23</xref>,<xref rid="B24-nutrients-10-01546" ref-type="bibr">24</xref>,<xref rid="B25-nutrients-10-01546" ref-type="bibr">25</xref>,<xref rid="B26-nutrients-10-01546" ref-type="bibr">26</xref>,<xref rid="B27-nutrients-10-01546" ref-type="bibr">27</xref>,<xref rid="B28-nutrients-10-01546" ref-type="bibr">28</xref>,<xref rid="B29-nutrients-10-01546" ref-type="bibr">29</xref>,<xref rid="B30-nutrients-10-01546" ref-type="bibr">30</xref>,<xref rid="B31-nutrients-10-01546" ref-type="bibr">31</xref>,<xref rid="B32-nutrients-10-01546" ref-type="bibr">32</xref>,<xref rid="B33-nutrients-10-01546" ref-type="bibr">33</xref>] were included in qualitative analysis, while four [<xref rid="B9-nutrients-10-01546" ref-type="bibr">9</xref>,<xref rid="B17-nutrients-10-01546" ref-type="bibr">17</xref>,<xref rid="B35-nutrients-10-01546" ref-type="bibr">35</xref>,<xref rid="B36-nutrients-10-01546" ref-type="bibr">36</xref>] were excluded for not complying with inclusion criteria.</p><p>The flowchart in <xref ref-type="fig" rid="nutrients-10-01546-f001">Figure 1</xref> represents the selection process for the inclusion of studies. </p><sec id="sec3dot1-nutrients-10-01546"><title>3.1. Characteristics of Included Studies and Primary Outcomes</title><p>All sixteen studies selected for the review were in-vitro studies published in English. The effects of FWGE were investigated on the following cell lines: <list list-type="simple"><list-item><label>(1)</label><p>Jurkat leukemic T cells were studied by three studies [<xref rid="B18-nutrients-10-01546" ref-type="bibr">18</xref>,<xref rid="B21-nutrients-10-01546" ref-type="bibr">21</xref>,<xref rid="B32-nutrients-10-01546" ref-type="bibr">32</xref>] and the treatment resulted in cytotoxic effects, alteration of the cell cycle, antiproliferative effects, and induction of apoptosis;</p></list-item><list-item><label>(2)</label><p>Lymphoma cells were subjected to the treatment and the effects investigated by three studies [<xref rid="B21-nutrients-10-01546" ref-type="bibr">21</xref>,<xref rid="B27-nutrients-10-01546" ref-type="bibr">27</xref>,<xref rid="B32-nutrients-10-01546" ref-type="bibr">32</xref>] showed growth inhibition, induction of apoptosis, antiproliferation, and cytotoxic effects;</p></list-item><list-item><label>(3)</label><p>Gastric cancer cell line experiments reported in three papers [<xref rid="B22-nutrients-10-01546" ref-type="bibr">22</xref>,<xref rid="B25-nutrients-10-01546" ref-type="bibr">25</xref>,<xref rid="B26-nutrients-10-01546" ref-type="bibr">26</xref>] found antiproliferative, cytotoxic, cytostatic, and growth-delay effects;</p></list-item><list-item><label>(4)</label><p>Ovarian cancer cell lines, when subjected to treatment with AVEMAR, showed cytotoxic effects [<xref rid="B23-nutrients-10-01546" ref-type="bibr">23</xref>], antiproliferative activity [<xref rid="B25-nutrients-10-01546" ref-type="bibr">25</xref>], and suppression of cell proliferation [<xref rid="B29-nutrients-10-01546" ref-type="bibr">29</xref>];</p></list-item><list-item><label>(5)</label><p>Breast cancer cell lines appeared to undergo cytotoxicity and apoptosis [<xref rid="B24-nutrients-10-01546" ref-type="bibr">24</xref>,<xref rid="B25-nutrients-10-01546" ref-type="bibr">25</xref>,<xref rid="B26-nutrients-10-01546" ref-type="bibr">26</xref>,<xref rid="B32-nutrients-10-01546" ref-type="bibr">32</xref>], while, in one study [<xref rid="B33-nutrients-10-01546" ref-type="bibr">33</xref>] investigating the combined administration of AVEMAR and cytostatics, the treatment with AVEMAR resulted in no increase or decrease of cell viability compared to untreated cells;</p></list-item><list-item><label>(6)</label><p>When applied to colon cancer cell lines, FWGE showed antiproliferative activity [<xref rid="B25-nutrients-10-01546" ref-type="bibr">25</xref>], cytotoxicity, cytostasis, and induction of cell apoptosis [<xref rid="B31-nutrients-10-01546" ref-type="bibr">31</xref>];</p></list-item><list-item><label>(7)</label><p>The treatment of hepatic cancer cells appeared to cause cytotoxicity, apoptosis [<xref rid="B32-nutrients-10-01546" ref-type="bibr">32</xref>], and an inhibition of proliferation [<xref rid="B25-nutrients-10-01546" ref-type="bibr">25</xref>,<xref rid="B28-nutrients-10-01546" ref-type="bibr">28</xref>];</p></list-item><list-item><label>(8)</label><p>Other types of cell lines investigated in the included studies were prostate cancer cells, endocervical adenocarcinoma [<xref rid="B22-nutrients-10-01546" ref-type="bibr">22</xref>], cervical epidermoid carcinoma cells [<xref rid="B25-nutrients-10-01546" ref-type="bibr">25</xref>], testicular cancer cell lines [<xref rid="B25-nutrients-10-01546" ref-type="bibr">25</xref>], head and neck cancer [<xref rid="B25-nutrients-10-01546" ref-type="bibr">25</xref>], thyroid and pancreatic cancer cells [<xref rid="B13-nutrients-10-01546" ref-type="bibr">13</xref>], melanoma, hepatoma, glioblastoma, neuroblastoma [<xref rid="B22-nutrients-10-01546" ref-type="bibr">22</xref>], and oral squamous carcinoma cells [<xref rid="B30-nutrients-10-01546" ref-type="bibr">30</xref>]. In all cases, the effects of AVEMAR treatment provided results similar to those previously mentioned.</p></list-item></list></p></sec><sec id="sec3dot2-nutrients-10-01546"><title>3.2. Secondary Outcomes</title><p>Additional results that emerged from the experiments include:<list list-type="simple"><list-item><label>(1)</label><p>Enzyme activities evaluation. In particular, FWGE was found to inhibit Glucose-6-phosphate dehydrogenase (G6PDH), Lactate dehydrogenase (LDH) and Hexokinase (HK) activity in Jurkat T-progeny leukemia cells [<xref rid="B18-nutrients-10-01546" ref-type="bibr">18</xref>]. The inhibition of ribonucleotide reductase (RR) activity in promyelocytic leukemia cells was established by Saiko et al. [<xref rid="B19-nutrients-10-01546" ref-type="bibr">19</xref>]. A suppression of the expression of matrix metalloproteinase-2 (MMP-2) and urokinase plasminogen activator (u-PA) was revealed in oral cancer cells (SCC-4) treated with Avemar [<xref rid="B30-nutrients-10-01546" ref-type="bibr">30</xref>];</p></list-item><list-item><label>(2)</label><p>Presumable anti-angiogenic effects of FWGE on human cervical carcinoma (HeLa) and human lung adenocarcinoma (A549) cells through the inhibition of vascular endothelial growth factor (VEGF) and cyclooxygenase-2 (Cox-2) levels [<xref rid="B22-nutrients-10-01546" ref-type="bibr">22</xref>];</p></list-item><list-item><label>(3)</label><p>Impaired glucose consumption and reduced production of lactic acid in some adenocarcinoma cell lines [<xref rid="B26-nutrients-10-01546" ref-type="bibr">26</xref>,<xref rid="B34-nutrients-10-01546" ref-type="bibr">34</xref>].</p></list-item></list></p></sec></sec><sec id="sec4-nutrients-10-01546"><title>4. Discussion</title><p>Nutraceuticals are gaining importance in the prevention and treatment of different diseases. In particular, cancer treatment is a challenge that is still ongoing because of the difficulties presented by conventional drugs, which are often accompanied by serious side effects and unsatisfactory results.</p><p>FWGE is a nutraceutical that has been reported to possess unique &#x0201c;cancer-fighting&#x0201d; characteristics [<xref rid="B13-nutrients-10-01546" ref-type="bibr">13</xref>]. Its antiproliferative and cytotoxic activity, as well as its induction of apoptosis in human cancer cells, have been affirmed by several studies [<xref rid="B18-nutrients-10-01546" ref-type="bibr">18</xref>,<xref rid="B21-nutrients-10-01546" ref-type="bibr">21</xref>,<xref rid="B24-nutrients-10-01546" ref-type="bibr">24</xref>]. Some studies [<xref rid="B18-nutrients-10-01546" ref-type="bibr">18</xref>,<xref rid="B26-nutrients-10-01546" ref-type="bibr">26</xref>,<xref rid="B34-nutrients-10-01546" ref-type="bibr">34</xref>] investigated the metabolic changes in tumor cells in response to the treatment with FWGE and revealed important alterations in enzymes involved in direct glucose oxidation (G6PDH), non-oxidative glucose utilization (transketolase) toward nucleic acid synthesis, glycolysis (LDH), and glucose activation (HK). The inhibition of the key pathways of sugar metabolism and DNA-synthesis seems to contribute to the proliferation inhibiting capacity of FWGE. Saiko et al. [<xref rid="B19-nutrients-10-01546" ref-type="bibr">19</xref>] found that treatment with AVEMAR carried a direct enzyme attenuation of ribonucleotide reductase, which was demonstrated to be significantly up-regulated in tumor cells. In another study [<xref rid="B21-nutrients-10-01546" ref-type="bibr">21</xref>], some early biochemical events, such as tyrosine phosphorylation and the increase of intracellular Ca<sup>2+</sup> concentration, occurred in response to the treatment and was associated with increased apoptosis of the tumor cells. Judson et al. [<xref rid="B23-nutrients-10-01546" ref-type="bibr">23</xref>] have also identified genes and molecular signaling pathways associated with FWGE activity on investigated cells and these pathways include hedgehog signaling, activin A signaling regulation, and regulation of GAP 1/Synthesis (G1/S) phases transition.</p><p>Moreover, some of the studies included in this review suggested that AVEMAR could potentially inhibit cancer cell migration and invasive capacities [<xref rid="B30-nutrients-10-01546" ref-type="bibr">30</xref>]. Such actions can be important especially for some types of tumors, such as the oral squamous cell carcinoma [<xref rid="B37-nutrients-10-01546" ref-type="bibr">37</xref>,<xref rid="B38-nutrients-10-01546" ref-type="bibr">38</xref>], for which the highest mortality is due to the ability of lymph node metastasis or metastasis to distant organs. Imir et al. [<xref rid="B22-nutrients-10-01546" ref-type="bibr">22</xref>] investigated the ability of FWGE to inhibit angiogenesis and obtained very encouraging results stating that AVEMAR exerts anti-angiogenic effects by inhibiting VEGF and Cox-2 gene expression. This mechanism of action has already been proposed for the anti-angiogenic activity of polyphenols and polyphenol-rich foods in &#x0201c;in vitro&#x0201d; and &#x0201c;in vivo&#x0201d; models of angiogenesis [<xref rid="B39-nutrients-10-01546" ref-type="bibr">39</xref>]. </p><p>Another important finding was that the treatment with AVEMAR results in widespread apoptosis in lymphoid tumor cells, but it does not induce apoptosis of healthy resting mononuclear cells [<xref rid="B21-nutrients-10-01546" ref-type="bibr">21</xref>].</p><p>In some studies, the association of FWGE with conventional anticancer drugs has also been investigated in order to search for possible solutions to overcome the drug resistance that frequently occurs during anticancer chemotherapy and limit the side effects that traditional treatments entail. The results are promising for the addition of this natural compound to cisplatin chemotherapy of epithelial ovarian cancer cell lines [<xref rid="B23-nutrients-10-01546" ref-type="bibr">23</xref>,<xref rid="B29-nutrients-10-01546" ref-type="bibr">29</xref>] and hepatocellular carcinoma cells [<xref rid="B28-nutrients-10-01546" ref-type="bibr">28</xref>], to tamoxifen in the treatment of breast cancer cells [<xref rid="B24-nutrients-10-01546" ref-type="bibr">24</xref>], to docetaxel in ovarian carcinoma cells [<xref rid="B29-nutrients-10-01546" ref-type="bibr">29</xref>], to 5-Fluorouracil (5-FU) in colon cancer cells [<xref rid="B25-nutrients-10-01546" ref-type="bibr">25</xref>], and to the treatment of hepatocellular carcinoma cells [<xref rid="B28-nutrients-10-01546" ref-type="bibr">28</xref>]. Only one study [<xref rid="B33-nutrients-10-01546" ref-type="bibr">33</xref>] reported poor results for simultaneous use of AVEMAR and Dacarbazine, 5-fluorouracyl, or Adriblastina, where the addition of the nutraceutical did not increase nor decrease the viability of any of the cell cultures. However, the authors concluded that, based on the findings in the literature that have stated immunomodulatory and antimetastatic effects of AVEMAR [<xref rid="B8-nutrients-10-01546" ref-type="bibr">8</xref>,<xref rid="B17-nutrients-10-01546" ref-type="bibr">17</xref>,<xref rid="B21-nutrients-10-01546" ref-type="bibr">21</xref>,<xref rid="B40-nutrients-10-01546" ref-type="bibr">40</xref>,<xref rid="B41-nutrients-10-01546" ref-type="bibr">41</xref>], the latter may be administered with cytostatic drugs without increasing toxicity or decreasing the antiproliferative effect of the cytostatics. Concordant conclusions were reached by Yeend et al. [<xref rid="B42-nutrients-10-01546" ref-type="bibr">42</xref>] in their systematic review that considered clinical studies evaluating the adjunction of AVEMAR to conventional cancer treatments when compared to conventional cancer treatment alone.</p><p>It should be noted that, in some of the included studies [<xref rid="B31-nutrients-10-01546" ref-type="bibr">31</xref>,<xref rid="B32-nutrients-10-01546" ref-type="bibr">32</xref>], the nutraceutical was not purchased from the manufacturing company, but instead produced in the laboratory through the use of <italic>Lactobacillus plantarum</italic> dy-1 on fresh wheat germ. Barisone et al. [<xref rid="B32-nutrients-10-01546" ref-type="bibr">32</xref>] described a different way of obtaining the fermented wheat germ extract by using <italic>Saccharomyces cerevisiae</italic>. They also compared the in vitro activity of FWGE with that of AVEMAR and concluded that the killing activity was equivalent [<xref rid="B32-nutrients-10-01546" ref-type="bibr">32</xref>].</p><p>An important aspect to consider when experimenting with new principles is their safety. Although wheat germ is a commonly consumed food with no known adverse effects, the toxicity of AVEMAR has been investigated in various studies as summarized by Heimbach et al. [<xref rid="B35-nutrients-10-01546" ref-type="bibr">35</xref>]. Though this study reported that the use of AVEMAR pulvis would not be expected to cause adverse effects, the scientific literature on this is sparse. Further in vitro and in vivo studies are needed to assure its product safety as an ingredient in dietary supplements or as an anticancer drug.</p></sec><sec id="sec5-nutrients-10-01546"><title>5. Conclusions</title><p>The available data suggest that FWGE can be a promising compound that can be integrated into or improve the current treatment of cancer. However, further in vitro and in vivo studies are necessary to prove its effectiveness and safety in humans.</p></sec></body><back><ack><title>Acknowledgments</title><p>All research has been financed by authors&#x02019; institution funds. The article processing charges were funded by a contribution on the funds of the 5x1000 IRPEF in favor of University of Foggia, in memory of Gianluca Montel.</p></ack><notes><title>Author Contributions</title><p>K.Z. and G.T. performed the search of the manuscripts, their analysis; V.C.A.C. and M.D. worked to the writing of the manuscript; C.A. performed the data collection, L.L.M. conceived the present review and supervised the findings of this review. </p></notes><notes><title>Funding</title><p>This research received no external funding. </p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-nutrients-10-01546"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>A.</given-names></name><name><surname>Ginnebaugh</surname><given-names>K.R.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Padhye</surname><given-names>S.B.</given-names></name><name><surname>Sarkar</surname><given-names>F.H.</given-names></name></person-group><article-title>Molecular targets of naturopathy in cancer research: Bridge to modern medicine</article-title><source>Nutrients</source><year>2015</year><volume>7</volume><fpage>321</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.3390/nu7010321</pub-id><?supplied-pmid 25569626?><pub-id pub-id-type="pmid">25569626</pub-id></element-citation></ref><ref id="B2-nutrients-10-01546"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ardito</surname><given-names>F.</given-names></name><name><surname>Pellegrino</surname><given-names>M.R.</given-names></name><name><surname>Perrone</surname><given-names>D.</given-names></name><name><surname>Troiano</surname><given-names>G.</given-names></name><name><surname>Cocco</surname><given-names>A.</given-names></name><name><surname>Lo Muzio</surname><given-names>L.</given-names></name></person-group><article-title>In vitro study on anti-cancer properties of genistein in tongue cancer</article-title><source>Onco Targets Ther.</source><year>2017</year><volume>10</volume><fpage>5405</fpage><lpage>5415</lpage><pub-id pub-id-type="doi">10.2147/OTT.S133632</pub-id><?supplied-pmid 29180873?><pub-id pub-id-type="pmid">29180873</pub-id></element-citation></ref><ref id="B3-nutrients-10-01546"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perrone</surname><given-names>D.</given-names></name><name><surname>Ardito</surname><given-names>F.</given-names></name><name><surname>Giannatempo</surname><given-names>G.</given-names></name><name><surname>Dioguardi</surname><given-names>M.</given-names></name><name><surname>Troiano</surname><given-names>G.</given-names></name><name><surname>Lo Russo</surname><given-names>L.</given-names></name><name><surname>DE Lillo</surname><given-names>A.</given-names></name><name><surname>Laino</surname><given-names>L.</given-names></name><name><surname>Lo Muzio</surname><given-names>L.</given-names></name></person-group><article-title>Biological and therapeutic activities, and anticancer properties of curcumin</article-title><source>Exp. Ther. Med.</source><year>2015</year><volume>10</volume><fpage>1615</fpage><lpage>1623</lpage><pub-id pub-id-type="doi">10.3892/etm.2015.2749</pub-id><?supplied-pmid 26640527?><pub-id pub-id-type="pmid">26640527</pub-id></element-citation></ref><ref id="B4-nutrients-10-01546"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvie</surname><given-names>M.</given-names></name></person-group><article-title>Nutritional supplements and cancer: Potential benefits and proven harms</article-title><source>Am. Soc. Clin. Oncol. Educ. Book</source><year>2014</year><fpage>e478</fpage><lpage>e486</lpage><pub-id pub-id-type="doi">10.14694/EdBook_AM.2014.34.e478</pub-id><?supplied-pmid 24857143?><pub-id pub-id-type="pmid">24857143</pub-id></element-citation></ref><ref id="B5-nutrients-10-01546"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zang</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Qiao</surname><given-names>L.</given-names></name></person-group><article-title>Curcumin: A promising agent targeting cancer stem cells</article-title><source>Anticancer Agents Med. Chem.</source><year>2014</year><volume>14</volume><fpage>787</fpage><lpage>792</lpage><pub-id pub-id-type="doi">10.2174/1871520614666140521114735</pub-id><?supplied-pmid 24851881?><pub-id pub-id-type="pmid">24851881</pub-id></element-citation></ref><ref id="B6-nutrients-10-01546"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>L.G.</given-names></name><name><surname>D&#x02019;Orazio</surname><given-names>J.A.</given-names></name><name><surname>Pearson</surname><given-names>K.J.</given-names></name></person-group><article-title>Resveratrol and cancer: Focus on in vivo evidence</article-title><source>Endocr. Relat. Cancer</source><year>2014</year><volume>21</volume><fpage>R209</fpage><lpage>R225</lpage><pub-id pub-id-type="doi">10.1530/ERC-13-0171</pub-id><?supplied-pmid 24500760?><pub-id pub-id-type="pmid">24500760</pub-id></element-citation></ref><ref id="B7-nutrients-10-01546"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Megna</surname><given-names>B.W.</given-names></name><name><surname>Carney</surname><given-names>P.R.</given-names></name><name><surname>Nukaya</surname><given-names>M.</given-names></name><name><surname>Geiger</surname><given-names>P.</given-names></name><name><surname>Kennedy</surname><given-names>G.D.</given-names></name></person-group><article-title>Indole-3-carbinol induces tumor cell death: Function follows form</article-title><source>J. Surg. Res.</source><year>2016</year><volume>204</volume><fpage>47</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2016.04.021</pub-id><?supplied-pmid 27451867?><pub-id pub-id-type="pmid">27451867</pub-id></element-citation></ref><ref id="B8-nutrients-10-01546"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hidvegi</surname><given-names>M.</given-names></name><name><surname>Raso</surname><given-names>E.</given-names></name><name><surname>Tomoskozi-Farkas</surname><given-names>R.</given-names></name><name><surname>Paku</surname><given-names>S.</given-names></name><name><surname>Lapis</surname><given-names>K.</given-names></name><name><surname>Szende</surname><given-names>B.</given-names></name></person-group><article-title>Effect of avemar and avemar + vitamin c on tumor growth and metastasis in experimental animals</article-title><source>Anticancer Res.</source><year>1998</year><volume>18</volume><fpage>2353</fpage><lpage>2358</lpage><?supplied-pmid 9703878?><pub-id pub-id-type="pmid">9703878</pub-id></element-citation></ref><ref id="B9-nutrients-10-01546"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Telekes</surname><given-names>A.</given-names></name><name><surname>Hegedus</surname><given-names>M.</given-names></name><name><surname>Chae</surname><given-names>C.H.</given-names></name><name><surname>Vekey</surname><given-names>K.</given-names></name></person-group><article-title>Avemar (wheat germ extract) in cancer prevention and treatment</article-title><source>Nutr. Cancer</source><year>2009</year><volume>61</volume><fpage>891</fpage><lpage>899</lpage><pub-id pub-id-type="doi">10.1080/01635580903285114</pub-id><?supplied-pmid 20155632?><pub-id pub-id-type="pmid">20155632</pub-id></element-citation></ref><ref id="B10-nutrients-10-01546"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Brien</surname><given-names>P.J.</given-names></name></person-group><article-title>Molecular mechanisms of quinone cytotoxicity</article-title><source>Chem. Biol. Interact.</source><year>1991</year><volume>80</volume><fpage>1</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/0009-2797(91)90029-7</pub-id><pub-id pub-id-type="pmid">1913977</pub-id></element-citation></ref><ref id="B11-nutrients-10-01546"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piccart-Gebhart</surname><given-names>M.J.</given-names></name></person-group><article-title>Anthracyclines and the tailoring of treatment for early breast cancer</article-title><source>N. Engl. J. Med.</source><year>2006</year><volume>354</volume><fpage>2177</fpage><lpage>2179</lpage><pub-id pub-id-type="doi">10.1056/NEJMe068065</pub-id><?supplied-pmid 16707755?><pub-id pub-id-type="pmid">16707755</pub-id></element-citation></ref><ref id="B12-nutrients-10-01546"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johanning</surname><given-names>G.L.</given-names></name><name><surname>Wang-Johanning</surname><given-names>F.</given-names></name></person-group><article-title>Efficacy of a medical nutriment in the treatment of cancer</article-title><source>Altern. Ther. Health Med.</source><year>2007</year><volume>13</volume><fpage>56</fpage><lpage>63</lpage><?supplied-pmid 17405680?><pub-id pub-id-type="pmid">17405680</pub-id></element-citation></ref><ref id="B13-nutrients-10-01546"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boros</surname><given-names>L.G.</given-names></name><name><surname>Nichelatti</surname><given-names>M.</given-names></name><name><surname>Shoenfeld</surname><given-names>Y.</given-names></name></person-group><article-title>Fermented wheat germ extract (avemar) in the treatment of cancer and autoimmune diseases</article-title><source>Ann. N. Y. Acad. Sci.</source><year>2005</year><volume>1051</volume><fpage>529</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.1196/annals.1361.097</pub-id><?supplied-pmid 16126993?><pub-id pub-id-type="pmid">16126993</pub-id></element-citation></ref><ref id="B14-nutrients-10-01546"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iyer</surname><given-names>A.</given-names></name><name><surname>Brown</surname><given-names>L.</given-names></name></person-group><article-title>Fermented wheat germ extract (avemar) in the treatment of cardiac remodeling and metabolic symptoms in rats</article-title><source>Evid. Based Complement. Altern. Med.</source><year>2011</year><volume>2011</volume><fpage>508957</fpage><pub-id pub-id-type="doi">10.1093/ecam/nep090</pub-id><?supplied-pmid 19622599?><pub-id pub-id-type="pmid">19622599</pub-id></element-citation></ref><ref id="B15-nutrients-10-01546"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Illmer</surname><given-names>C.</given-names></name><name><surname>Madlener</surname><given-names>S.</given-names></name><name><surname>Horvath</surname><given-names>Z.</given-names></name><name><surname>Saiko</surname><given-names>P.</given-names></name><name><surname>Losert</surname><given-names>A.</given-names></name><name><surname>Herbacek</surname><given-names>I.</given-names></name><name><surname>Grusch</surname><given-names>M.</given-names></name><name><surname>Krupitza</surname><given-names>G.</given-names></name><name><surname>Fritzer-Szekeres</surname><given-names>M.</given-names></name><name><surname>Szekeres</surname><given-names>T.</given-names></name></person-group><article-title>Immunologic and biochemical effects of the fermented wheat germ extract avemar</article-title><source>Exp. Biol. Med.</source><year>2005</year><volume>230</volume><fpage>144</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1177/153537020523000209</pub-id></element-citation></ref><ref id="B16-nutrients-10-01546"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatenby</surname><given-names>R.A.</given-names></name><name><surname>Gillies</surname><given-names>R.J.</given-names></name></person-group><article-title>Why do cancers have high aerobic glycolysis?</article-title><source>Nat. Rev. Cancer</source><year>2004</year><volume>4</volume><fpage>891</fpage><lpage>899</lpage><pub-id pub-id-type="doi">10.1038/nrc1478</pub-id><?supplied-pmid 15516961?><pub-id pub-id-type="pmid">15516961</pub-id></element-citation></ref><ref id="B17-nutrients-10-01546"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hidvegi</surname><given-names>M.</given-names></name><name><surname>Raso</surname><given-names>E.</given-names></name><name><surname>Tomoskozi-Farkas</surname><given-names>R.</given-names></name><name><surname>Szende</surname><given-names>B.</given-names></name><name><surname>Paku</surname><given-names>S.</given-names></name><name><surname>Pronai</surname><given-names>L.</given-names></name><name><surname>Bocsi</surname><given-names>J.</given-names></name><name><surname>Lapis</surname><given-names>K.</given-names></name></person-group><article-title>Msc, a new benzoquinone-containing natural product with antimetastatic effect</article-title><source>Cancer Biother. Radiopharm.</source><year>1999</year><volume>14</volume><fpage>277</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1089/cbr.1999.14.277</pub-id><?supplied-pmid 10850313?><pub-id pub-id-type="pmid">10850313</pub-id></element-citation></ref><ref id="B18-nutrients-10-01546"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comin-Anduix</surname><given-names>B.</given-names></name><name><surname>Boros</surname><given-names>L.G.</given-names></name><name><surname>Marin</surname><given-names>S.</given-names></name><name><surname>Boren</surname><given-names>J.</given-names></name><name><surname>Callol-Massot</surname><given-names>C.</given-names></name><name><surname>Centelles</surname><given-names>J.J.</given-names></name><name><surname>Torres</surname><given-names>J.L.</given-names></name><name><surname>Agell</surname><given-names>N.</given-names></name><name><surname>Bassilian</surname><given-names>S.</given-names></name><name><surname>Cascante</surname><given-names>M.</given-names></name></person-group><article-title>Fermented wheat germ extract inhibits glycolysis/pentose cycle enzymes and induces apoptosis through poly(ADP-ribose) polymerase activation in jurkat T-cell leukemia tumor cells</article-title><source>J. Biol. Chem.</source><year>2002</year><volume>277</volume><fpage>46408</fpage><lpage>46414</lpage><pub-id pub-id-type="doi">10.1074/jbc.M206150200</pub-id><?supplied-pmid 12351627?><pub-id pub-id-type="pmid">12351627</pub-id></element-citation></ref><ref id="B19-nutrients-10-01546"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saiko</surname><given-names>P.</given-names></name><name><surname>Ozsvar-Kozma</surname><given-names>M.</given-names></name><name><surname>Madlener</surname><given-names>S.</given-names></name><name><surname>Bernhaus</surname><given-names>A.</given-names></name><name><surname>Lackner</surname><given-names>A.</given-names></name><name><surname>Grusch</surname><given-names>M.</given-names></name><name><surname>Horvath</surname><given-names>Z.</given-names></name><name><surname>Krupitza</surname><given-names>G.</given-names></name><name><surname>Jaeger</surname><given-names>W.</given-names></name><name><surname>Ammer</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Avemar, a nontoxic fermented wheat germ extract, induces apoptosis and inhibits ribonucleotide reductase in human HL-60 promyelocytic leukemia cells</article-title><source>Cancer Lett.</source><year>2007</year><volume>250</volume><fpage>323</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2006.10.018</pub-id><?supplied-pmid 17137710?><pub-id pub-id-type="pmid">17137710</pub-id></element-citation></ref><ref id="B20-nutrients-10-01546"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liberati</surname><given-names>A.</given-names></name><name><surname>Altman</surname><given-names>D.G.</given-names></name><name><surname>Tetzlaff</surname><given-names>J.</given-names></name><name><surname>Mulrow</surname><given-names>C.</given-names></name><name><surname>Gotzsche</surname><given-names>P.C.</given-names></name><name><surname>Ioannidis</surname><given-names>J.P.</given-names></name><name><surname>Clarke</surname><given-names>M.</given-names></name><name><surname>Devereaux</surname><given-names>P.J.</given-names></name><name><surname>Kleijnen</surname><given-names>J.</given-names></name><name><surname>Moher</surname><given-names>D.</given-names></name></person-group><article-title>The prisma statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration</article-title><source>J. Clin. Epidemiol.</source><year>2009</year><volume>62</volume><fpage>e1</fpage><lpage>e34</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2009.06.006</pub-id><?supplied-pmid 19631507?><pub-id pub-id-type="pmid">19631507</pub-id></element-citation></ref><ref id="B21-nutrients-10-01546"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fajka-Boja</surname><given-names>R.</given-names></name><name><surname>Hidvegi</surname><given-names>M.</given-names></name><name><surname>Shoenfeld</surname><given-names>Y.</given-names></name><name><surname>Ion</surname><given-names>G.</given-names></name><name><surname>Demydenko</surname><given-names>D.</given-names></name><name><surname>Tomoskozi-Farkas</surname><given-names>R.</given-names></name><name><surname>Vizler</surname><given-names>C.</given-names></name><name><surname>Telekes</surname><given-names>A.</given-names></name><name><surname>Resetar</surname><given-names>A.</given-names></name><name><surname>Monostori</surname><given-names>E.</given-names></name></person-group><article-title>Fermented wheat germ extract induces apoptosis and downregulation of major histocompatibility complex class i proteins in tumor t and b cell lines</article-title><source>Int. J. Oncol.</source><year>2002</year><volume>20</volume><fpage>563</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.3892/ijo.20.3.563</pub-id><?supplied-pmid 11836569?><pub-id pub-id-type="pmid">11836569</pub-id></element-citation></ref><ref id="B22-nutrients-10-01546"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imir</surname><given-names>N.G.</given-names></name><name><surname>Aydemir</surname><given-names>E.</given-names></name><name><surname>Simsek</surname><given-names>E.</given-names></name></person-group><article-title>Mechanism of the anti-angiogenic effect of avemar on tumor cells</article-title><source>Oncol. Lett.</source><year>2018</year><volume>15</volume><fpage>2673</fpage><lpage>2678</lpage><pub-id pub-id-type="doi">10.3892/ol.2017.7604</pub-id><?supplied-pmid 29434991?><pub-id pub-id-type="pmid">29434991</pub-id></element-citation></ref><ref id="B23-nutrients-10-01546"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Judson</surname><given-names>P.L.</given-names></name><name><surname>Al Sawah</surname><given-names>E.</given-names></name><name><surname>Marchion</surname><given-names>D.C.</given-names></name><name><surname>Xiong</surname><given-names>Y.</given-names></name><name><surname>Bicaku</surname><given-names>E.</given-names></name><name><surname>Bou Zgheib</surname><given-names>N.</given-names></name><name><surname>Chon</surname><given-names>H.S.</given-names></name><name><surname>Stickles</surname><given-names>X.B.</given-names></name><name><surname>Hakam</surname><given-names>A.</given-names></name><name><surname>Wenham</surname><given-names>R.M.</given-names></name><etal/></person-group><article-title>Characterizing the efficacy of fermented wheat germ extract against ovarian cancer and defining the genomic basis of its activity</article-title><source>Int. J. Gynecol. Cancer</source><year>2012</year><volume>22</volume><fpage>960</fpage><lpage>967</lpage><pub-id pub-id-type="doi">10.1097/IGC.0b013e318258509d</pub-id><?supplied-pmid 22740002?><pub-id pub-id-type="pmid">22740002</pub-id></element-citation></ref><ref id="B24-nutrients-10-01546"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcsek</surname><given-names>Z.</given-names></name><name><surname>Kocsis</surname><given-names>Z.</given-names></name><name><surname>Jakab</surname><given-names>M.</given-names></name><name><surname>Szende</surname><given-names>B.</given-names></name><name><surname>Tompa</surname><given-names>A.</given-names></name></person-group><article-title>The efficacy of tamoxifen in estrogen receptor-positive breast cancer cells is enhanced by a medical nutriment</article-title><source>Cancer Biother. Radiopharm.</source><year>2004</year><volume>19</volume><fpage>746</fpage><lpage>753</lpage><pub-id pub-id-type="doi">10.1089/cbr.2004.19.746</pub-id><?supplied-pmid 15665622?><pub-id pub-id-type="pmid">15665622</pub-id></element-citation></ref><ref id="B25-nutrients-10-01546"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>T.</given-names></name><name><surname>Jordan</surname><given-names>K.</given-names></name><name><surname>Voigt</surname><given-names>W.</given-names></name></person-group><article-title>Promising cytotoxic activity profile of fermented wheat germ extract (Avemar<sup>&#x000ae;</sup>) in human cancer cell lines</article-title><source>J. Exp. Clin. Cancer Res.</source><year>2011</year><volume>30</volume><fpage>42</fpage><pub-id pub-id-type="doi">10.1186/1756-9966-30-42</pub-id><?supplied-pmid 21496306?><pub-id pub-id-type="pmid">21496306</pub-id></element-citation></ref><ref id="B26-nutrients-10-01546"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otto</surname><given-names>C.</given-names></name><name><surname>Hahlbrock</surname><given-names>T.</given-names></name><name><surname>Eich</surname><given-names>K.</given-names></name><name><surname>Karaaslan</surname><given-names>F.</given-names></name><name><surname>Jurgens</surname><given-names>C.</given-names></name><name><surname>Germer</surname><given-names>C.T.</given-names></name><name><surname>Wiegering</surname><given-names>A.</given-names></name><name><surname>Kammerer</surname><given-names>U.</given-names></name></person-group><article-title>Antiproliferative and antimetabolic effects behind the anticancer property of fermented wheat germ extract</article-title><source>BMC Complement. Altern. Med.</source><year>2016</year><volume>16</volume><elocation-id>160</elocation-id><pub-id pub-id-type="doi">10.1186/s12906-016-1138-5</pub-id><?supplied-pmid 27245162?><pub-id pub-id-type="pmid">27245162</pub-id></element-citation></ref><ref id="B27-nutrients-10-01546"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saiko</surname><given-names>P.</given-names></name><name><surname>Ozsvar-Kozma</surname><given-names>M.</given-names></name><name><surname>Graser</surname><given-names>G.</given-names></name><name><surname>Lackner</surname><given-names>A.</given-names></name><name><surname>Grusch</surname><given-names>M.</given-names></name><name><surname>Madlener</surname><given-names>S.</given-names></name><name><surname>Krupitza</surname><given-names>G.</given-names></name><name><surname>Jaeger</surname><given-names>W.</given-names></name><name><surname>Hidvegi</surname><given-names>M.</given-names></name><name><surname>Agarwal</surname><given-names>R.P.</given-names></name><etal/></person-group><article-title>Avemar, a nontoxic fermented wheat germ extract, attenuates the growth of sensitive and 5-FdUrd/Ara-c cross-resistant H9 human lymphoma cells through induction of apoptosis</article-title><source>Oncol. Rep.</source><year>2009</year><volume>21</volume><fpage>787</fpage><lpage>791</lpage><?supplied-pmid 19212640?><pub-id pub-id-type="pmid">19212640</pub-id></element-citation></ref><ref id="B28-nutrients-10-01546"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tai</surname><given-names>C.J.</given-names></name><name><surname>Wang</surname><given-names>W.C.</given-names></name><name><surname>Wang</surname><given-names>C.K.</given-names></name><name><surname>Wu</surname><given-names>C.H.</given-names></name><name><surname>Yang</surname><given-names>M.D.</given-names></name><name><surname>Chang</surname><given-names>Y.J.</given-names></name><name><surname>Jian</surname><given-names>J.Y.</given-names></name><name><surname>Tai</surname><given-names>C.J.</given-names></name></person-group><article-title>Fermented wheat germ extract induced cell death and enhanced cytotoxicity of cisplatin and 5-fluorouracil on human hepatocellular carcinoma cells</article-title><source>Evid. Based Complement. Altern. Med.</source><year>2013</year><volume>2013</volume><fpage>121725</fpage><pub-id pub-id-type="doi">10.1155/2013/121725</pub-id><?supplied-pmid 24454483?><pub-id pub-id-type="pmid">24454483</pub-id></element-citation></ref><ref id="B29-nutrients-10-01546"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C.W.</given-names></name><name><surname>Wang</surname><given-names>C.K.</given-names></name><name><surname>Chang</surname><given-names>Y.J.</given-names></name><name><surname>Choong</surname><given-names>C.Y.</given-names></name><name><surname>Lin</surname><given-names>C.S.</given-names></name><name><surname>Tai</surname><given-names>C.J.</given-names></name><name><surname>Tai</surname><given-names>C.J.</given-names></name></person-group><article-title>Preclinical evaluation on the tumor suppression efficiency and combination drug effects of fermented wheat germ extract in human ovarian carcinoma cells</article-title><source>Evid. Based Complement. Altern. Med.</source><year>2015</year><volume>2015</volume><fpage>570785</fpage><pub-id pub-id-type="doi">10.1155/2015/570785</pub-id><?supplied-pmid 25815037?><pub-id pub-id-type="pmid">25815037</pub-id></element-citation></ref><ref id="B30-nutrients-10-01546"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>M.D.</given-names></name><name><surname>Chang</surname><given-names>W.S.</given-names></name><name><surname>Tsai</surname><given-names>C.W.</given-names></name><name><surname>Wang</surname><given-names>M.F.</given-names></name><name><surname>Chan</surname><given-names>Y.C.</given-names></name><name><surname>Chan</surname><given-names>K.C.</given-names></name><name><surname>Lu</surname><given-names>M.C.</given-names></name><name><surname>Kao</surname><given-names>A.W.</given-names></name><name><surname>Hsu</surname><given-names>C.M.</given-names></name><name><surname>Bau</surname><given-names>D.T.</given-names></name></person-group><article-title>Inhibitory effects of avemar on proliferation and metastasis of oral cancer cells</article-title><source>Nutr. Cancer</source><year>2016</year><volume>68</volume><fpage>473</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1080/01635581.2016.1153668</pub-id><?supplied-pmid 27007465?><pub-id pub-id-type="pmid">27007465</pub-id></element-citation></ref><ref id="B31-nutrients-10-01546"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.Y.</given-names></name><name><surname>Xiao</surname><given-names>X.</given-names></name><name><surname>Dong</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Yao</surname><given-names>F.</given-names></name><name><surname>Zhou</surname><given-names>X.H.</given-names></name></person-group><article-title>Effect of fermented wheat germ extract with lactobacillus plantarum dy-1 on ht-29 cell proliferation and apoptosis</article-title><source>J. Agric. Food Chem.</source><year>2015</year><volume>63</volume><fpage>2449</fpage><lpage>2457</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.5b00041</pub-id><?supplied-pmid 25658135?><pub-id pub-id-type="pmid">25658135</pub-id></element-citation></ref><ref id="B32-nutrients-10-01546"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barisone</surname><given-names>G.A.</given-names></name><name><surname>O&#x02019;Donnell</surname><given-names>R.T.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Abuhay</surname><given-names>M.W.</given-names></name><name><surname>Lundeberg</surname><given-names>K.</given-names></name><name><surname>Gowda</surname><given-names>S.</given-names></name><name><surname>Tuscano</surname><given-names>J.M.</given-names></name></person-group><article-title>A purified, fermented, extract of triticum aestivum has lymphomacidal activity mediated via natural killer cell activation</article-title><source>PLoS ONE</source><year>2018</year><volume>13</volume><elocation-id>e0190860</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0190860</pub-id><?supplied-pmid 29304125?><pub-id pub-id-type="pmid">29304125</pub-id></element-citation></ref><ref id="B33-nutrients-10-01546"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szende</surname><given-names>B.</given-names></name><name><surname>Marcsek</surname><given-names>Z.</given-names></name><name><surname>Kocsis</surname><given-names>Z.</given-names></name><name><surname>Tompa</surname><given-names>A.</given-names></name></person-group><article-title>Effect of simultaneous administration of avemar<sup>&#x000ae;</sup> and cytostatic drugs on viability of cell cultures, growth of experimental tumors, and survival of tumor-bearing mice</article-title><source>Cancer Biother. Radiopharm.</source><year>2004</year><volume>19</volume><fpage>343</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1089/1084978041425016</pub-id><?supplied-pmid 15285880?><pub-id pub-id-type="pmid">15285880</pub-id></element-citation></ref><ref id="B34-nutrients-10-01546"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boros</surname><given-names>L.G.</given-names></name><name><surname>Lapis</surname><given-names>K.</given-names></name><name><surname>Szende</surname><given-names>B.</given-names></name><name><surname>T&#x000f6;m&#x000f6;sk&#x000f6;zi-Farkas</surname><given-names>R.</given-names></name><name><surname>Balogh</surname><given-names>A.</given-names></name><name><surname>Boren</surname><given-names>J.</given-names></name><name><surname>Marin</surname><given-names>S.</given-names></name><name><surname>Cascante</surname><given-names>M.</given-names></name><name><surname>Hidv&#x000e9;gi</surname><given-names>M.</given-names></name></person-group><article-title>Wheat germ extract decreases glucose uptake and rna ribose formation but increases fatty acid synthesis in mia pancreatic adenocarcinoma cells</article-title><source>Pancreas</source><year>2001</year><volume>23</volume><fpage>141</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1097/00006676-200108000-00004</pub-id><?supplied-pmid 11484916?><pub-id pub-id-type="pmid">11484916</pub-id></element-citation></ref><ref id="B35-nutrients-10-01546"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heimbach</surname><given-names>J.T.</given-names></name><name><surname>Sebestyen</surname><given-names>G.</given-names></name><name><surname>Semjen</surname><given-names>G.</given-names></name><name><surname>Kennepohl</surname><given-names>E.</given-names></name></person-group><article-title>Safety studies regarding a standardized extract of fermented wheat germ</article-title><source>Int. J. Toxicol.</source><year>2007</year><volume>26</volume><fpage>253</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1080/10915810701369709</pub-id><?supplied-pmid 17564907?><pub-id pub-id-type="pmid">17564907</pub-id></element-citation></ref><ref id="B36-nutrients-10-01546"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shibuya</surname><given-names>N.</given-names></name><name><surname>Inoue</surname><given-names>K.</given-names></name><name><surname>Tanaka</surname><given-names>G.</given-names></name><name><surname>Akimoto</surname><given-names>K.</given-names></name><name><surname>Kubota</surname><given-names>K.</given-names></name></person-group><article-title>Augmented pentose phosphate pathway plays critical roles in colorectal carcinomas</article-title><source>Oncology</source><year>2015</year><volume>88</volume><fpage>309</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1159/000369905</pub-id><?supplied-pmid 25591719?><pub-id pub-id-type="pmid">25591719</pub-id></element-citation></ref><ref id="B37-nutrients-10-01546"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kudo</surname><given-names>Y.</given-names></name><name><surname>Kitajjma</surname><given-names>S.</given-names></name><name><surname>Sato</surname><given-names>S.</given-names></name><name><surname>Miyauchi</surname><given-names>M.</given-names></name><name><surname>Ogawa</surname><given-names>I.</given-names></name><name><surname>Takata</surname><given-names>T.</given-names></name></person-group><article-title>Establishment of an oral squamous cell carcinoma cell line with high invasive and p27 degradation activities from a lymph node metastasis</article-title><source>Oral Oncol.</source><year>2003</year><volume>39</volume><fpage>515</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1016/S1368-8375(03)00015-0</pub-id><pub-id pub-id-type="pmid">12747977</pub-id></element-citation></ref><ref id="B38-nutrients-10-01546"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo Muzio</surname><given-names>L.</given-names></name><name><surname>Pannone</surname><given-names>G.</given-names></name><name><surname>Santarelli</surname><given-names>A.</given-names></name><name><surname>Bambini</surname><given-names>F.</given-names></name><name><surname>Mascitti</surname><given-names>M.</given-names></name><name><surname>Rubini</surname><given-names>C.</given-names></name><name><surname>Testa</surname><given-names>N.F.</given-names></name><name><surname>Dioguardi</surname><given-names>M.</given-names></name><name><surname>Leuci</surname><given-names>S.</given-names></name><name><surname>Bascones</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Is expression of p120ctn in oral squamous cell carcinomas a prognostic factor?</article-title><source>Oral Surg. Oral Med. Oral Pathol. Oral Radiol.</source><year>2013</year><volume>115</volume><fpage>789</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1016/j.oooo.2013.03.006</pub-id><?supplied-pmid 23706919?><pub-id pub-id-type="pmid">23706919</pub-id></element-citation></ref><ref id="B39-nutrients-10-01546"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scoditti</surname><given-names>E.</given-names></name><name><surname>Calabriso</surname><given-names>N.</given-names></name><name><surname>Massaro</surname><given-names>M.</given-names></name><name><surname>Pellegrino</surname><given-names>M.</given-names></name><name><surname>Storelli</surname><given-names>C.</given-names></name><name><surname>Martines</surname><given-names>G.</given-names></name><name><surname>De Caterina</surname><given-names>R.</given-names></name><name><surname>Carluccio</surname><given-names>M.A.</given-names></name></person-group><article-title>Mediterranean diet polyphenols reduce inflammatory angiogenesis through mmp-9 and cox-2 inhibition in human vascular endothelial cells: A potentially protective mechanism in atherosclerotic vascular disease and cancer</article-title><source>Arch. Biochem. Biophys.</source><year>2012</year><volume>527</volume><fpage>81</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2012.05.003</pub-id><?supplied-pmid 22595400?><pub-id pub-id-type="pmid">22595400</pub-id></element-citation></ref><ref id="B40-nutrients-10-01546"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hidvegi</surname><given-names>M.</given-names></name><name><surname>Raso</surname><given-names>E.</given-names></name><name><surname>Tomoskozi Farkas</surname><given-names>R.</given-names></name><name><surname>Lapis</surname><given-names>K.</given-names></name><name><surname>Szende</surname><given-names>B.</given-names></name></person-group><article-title>Effect of msc on the immune response of mice</article-title><source>Immunopharmacology</source><year>1999</year><volume>41</volume><fpage>183</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1016/S0162-3109(99)00002-8</pub-id><pub-id pub-id-type="pmid">10428646</pub-id></element-citation></ref><ref id="B41-nutrients-10-01546"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakab</surname><given-names>F.</given-names></name><name><surname>Shoenfeld</surname><given-names>Y.</given-names></name><name><surname>Balogh</surname><given-names>A.</given-names></name><name><surname>Nichelatti</surname><given-names>M.</given-names></name><name><surname>Hoffmann</surname><given-names>A.</given-names></name><name><surname>Kahan</surname><given-names>Z.</given-names></name><name><surname>Lapis</surname><given-names>K.</given-names></name><name><surname>Mayer</surname><given-names>A.</given-names></name><name><surname>Sapy</surname><given-names>P.</given-names></name><name><surname>Szentpetery</surname><given-names>F.</given-names></name><etal/></person-group><article-title>A medical nutriment has supportive value in the treatment of colorectal cancer</article-title><source>Br. J. Cancer</source><year>2003</year><volume>89</volume><fpage>465</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1038/sj.bjc.6601153</pub-id><?supplied-pmid 12888813?><pub-id pub-id-type="pmid">12888813</pub-id></element-citation></ref><ref id="B42-nutrients-10-01546"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeend</surname><given-names>T.</given-names></name><name><surname>Robinson</surname><given-names>K.</given-names></name><name><surname>Lockwood</surname><given-names>C.</given-names></name><name><surname>McArthur</surname><given-names>A.</given-names></name></person-group><article-title>The effectiveness of fermented wheat germ extract as an adjunct therapy in the treatment of cancer: A systematic review</article-title><source>JBI Libr. Syst. Rev.</source><year>2012</year><volume>10</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.11124/jbisrir-2012-289</pub-id><?supplied-pmid 27820157?><pub-id pub-id-type="pmid">27820157</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="nutrients-10-01546-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Flowchart of the selection process for the studies inclusion.</p></caption><graphic xlink:href="nutrients-10-01546-g001"/></fig><table-wrap id="nutrients-10-01546-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">nutrients-10-01546-t001_Table 1</object-id><label>Table 1</label><caption><p>Main data of the included studies, reporting the first author, the year of publication, the title, the types of the cells subjected to the treatment, the investigation procedures performed, and the main results of the experiments.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Author</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Year</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Title</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Type</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Investigations</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Main Results</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Secondary Outcomes</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Comin-Anduix et al. [<xref rid="B18-nutrients-10-01546" ref-type="bibr">18</xref>]</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2002</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fermented Wheat Germ Extract Inhibits Glycolysis/Pentose<break/>Cycle Enzymes and Induces Apoptosis through Poly (ADP-ribose) Polymerase Activation in Jurkat T-cell Leukemia Tumor Cells.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Jurkat T-cell Leukemia Tumor Cells.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell cycle analysis, cell viability assay, assessment of apoptosis.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effects, alteration of the cell cycle, induction of apoptosis.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cleavage of PARP, Transketolase, G6PDH, HK, LDH inhibition. </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Fajka-boja et al. [<xref rid="B21-nutrients-10-01546" ref-type="bibr">21</xref>]</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2002</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fermented wheat germ extract induces apoptosis and downregulation of major histocompatibility complex class I proteins in tumor T and B cell lines.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Jurkat leukemic T cells, Burkitt lymphoma B cell lines, myelo-monocytic cell line.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Detection of apoptotic cells, measurement of cell proliferation.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis, antiproliferative effect.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Elevation of intracellular Ca<sup>2+</sup> concentration.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Imir et al. [<xref rid="B22-nutrients-10-01546" ref-type="bibr">22</xref>]</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2018</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mechanism of the anti-angiogenic effect of AVEMAR on tumor cells.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NCI-N87 (gastric tubular adenocarcinoma), PC3 (prostate carcinoma), HeLa (adenocarcinoma) and A549 (lung adenocarcinoma)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Investigation of anti-angiogenic effects.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of induced VEGF levels.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of Cox-2 levels.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Judson et al. [<xref rid="B23-nutrients-10-01546" ref-type="bibr">23</xref>]</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2012</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Characterizing the efficacy of fermented wheat germ extract against ovarian cancer and defining the genomic basis of its activity.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ovarian cancer cell lines.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell viability assays.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effects, increase of cisplatin sensitivity.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Marcsek et al. [<xref rid="B24-nutrients-10-01546" ref-type="bibr">24</xref>]</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2004</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">The Efficacy of Tamoxifen in Estrogen Receptor&#x02013;Positive Breast Cancer Cells Is Enhanced by a Medical Nutriment.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MCF-7 breast cancer cells.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic effects evaluation, detection of apoptosis and mitosis, evaluation of tamoxifen-combined treatment.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxicity, induction of apoptosis.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Mueller et al. [<xref rid="B25-nutrients-10-01546" ref-type="bibr">25</xref>]</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2011</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Promising cytotoxic activity profile of fermented wheat germ extract (Avemar<sup>&#x000ae;</sup>) in human cancer cell lines.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">testicular cancer (H12.1, 2102EP, 1411HP, 1777NRpmet), colon cancer (HCT-8, HCT-15, HCT-116, HT-29, DLD-1, SW480, COLO205, COLO320DM), NSCLC (A549, A427, H322, H358), head and neck cancer (FADU, A253), cervical epidermoid<break/>carcinoma (A431), mammary adenocarcinoma (MCF-7, BT474), ovarian adenocarcinoma (A2780), gastric Cancer (M2), anaplastic thyroid cancer (8505C, SW1736), papillary thyroid cancer (BCPAP), follicular thyroid cancer (FTC133), melanoma, hepatoma (HepG2), glioblastoma (U87MG), neuroblastoma (SHSY5Y, SIMA).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Growth inhibition experiments, apoptosis evaluation. </td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antiproliferative activity.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Otto et al. [<xref rid="B26-nutrients-10-01546" ref-type="bibr">26</xref>]</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antiproliferative and antimetabolic effects behind the anticancer property of fermented wheat germ extract.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adenocarcinoma of the breast (MDA-MB-468) and (MDA-MB-231) and (BT-20), adenocarcinoma of the pancreas (ASPC-1) and (BxPC-3), adenocarcinoma of the stomach (23132/87), adenocarcinoma of the colon (HT-29) and (HRT-18), invasive breast ductal carcinoma (MCF-7).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Effects on cell growth, Cell cycle analysis.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic, antiproliferative and growth delay effects.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Depletion in cellular ATP and decrease in the NADH/NAD+ ratio.<break/>Impaired glucose consumption and significantly reduced production of lactic acid.<break/>Induction of autophagy in HRT-18 cells.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Saiko et al. [<xref rid="B19-nutrients-10-01546" ref-type="bibr">19</xref>]</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2007</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Avemar, a nontoxic fermented wheat germ extract, induces apoptosis and inhibits ribonucleotide reductase in human HL-60 promyelocytic leukemia cells.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human HL-60 promyelocytic leukemia cells.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Apoptosis evaluation, cell cycle distribution analysis.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of apoptosis, cell growth inhibition.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Decreasing of dNTPs, direct enzyme attenuation (ribonucleotide reductase; RR).</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Saiko et al. [<xref rid="B27-nutrients-10-01546" ref-type="bibr">27</xref>]</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2009</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Avemar, a nontoxic fermented wheat germ extract, attenuates the growth of sensitive and 5-FdUrd/Ara-C cross-resistant H9 human lymphoma cells through induction of apoptosis.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human lymphoma cells H9, 5-FdUrd/Ara-C cross-resistant H9 human lymphoma cell line.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Growth inhibition assay, apoptosis evaluation.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Growth inhibition, induction of apoptosis.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Tai et al. [<xref rid="B28-nutrients-10-01546" ref-type="bibr">28</xref>]</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2013</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fermented Wheat Germ Extract Induced Cell Death and Enhanced Cytotoxicity of Cisplatin and 5-Fluorouracil on Human Hepatocellular Carcinoma Cells.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hepatocellular carcinoma (HCC) HepG2, Hep3B, and HepJ5 cells.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell viability Assay, evaluation of cisplatin and 5-fluorouracil combined treatment.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antiproliferative activity, enhanced cytotoxicity of chemotherapeutic.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Wang et al. [<xref rid="B29-nutrients-10-01546" ref-type="bibr">29</xref>]</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2015</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Preclinical Evaluation on the Tumor Suppression Efficiency and Combination Drug Effects of Fermented Wheat Germ Extract in Human Ovarian Carcinoma Cells.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SKOV-3 and ES-2 human ovarian carcinoma cells.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell viability evaluation, cell death markers analysis, evaluation of cisplatin- or docetaxel-combined treatment.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Suppression of cell proliferation, caspase-related apoptosis activation, increased cytotoxicity of cisplatin and docetaxel.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Yang et al. [<xref rid="B30-nutrients-10-01546" ref-type="bibr">30</xref>]</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibitory Effects of AVEMAR on Proliferation and Metastasis of Oral Cancer Cells.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human oral squamous carcinoma SCC-4 cells.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cell viability evaluation, cell apoptosis assay wound-healing migration assay, cell invasion assay.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of cell viability, induction of cell apoptosis, suppression of migration and invasion capacity.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Zhang et al. [<xref rid="B31-nutrients-10-01546" ref-type="bibr">31</xref>]</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2015</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Effect of Fermented Wheat Germ Extract with Lactobacillus plantarum dy-1 on HT-29 Cell Proliferation and Apoptosis.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human HT-29 colon cancer cells.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Growth inhibition assay, assessment of apoptosis.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High antiproliferative effects, induction of cell apoptosis.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Barisone et al. [<xref rid="B32-nutrients-10-01546" ref-type="bibr">32</xref>]</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2017</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A purified, fermented, extract of Triticum aestivum has lymphomacidal activity mediated via natural killer cell activation.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lymphoma cells, T-cell leukemia (Jurkat), lung (H1650), breast (MCF-7) and hepatic (HepG2) cancer cell lines.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic activity assay, apoptosis and cell cycle.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxic activity, apoptotic activity.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Szende et al. [<xref rid="B33-nutrients-10-01546" ref-type="bibr">33</xref>]</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2004</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Effect of Simultaneous Administration of Avemar<sup>&#x000ae;</sup> and Cytostatic Drugs on Viability of Cell Cultures, Growth of Experimental Tumors, and Survival of Tumor-Bearing Mice.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human breast adenocarcinoma cell line (MCF-7), hepatocyte carcinoma (HepG2).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytotoxicity testing of Avemar associated with various cytostatic drugs (5 FU, Dacarbazine, Adriblastina).</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Did not increase nor decrease cell viability.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Boros et al. [<xref rid="B34-nutrients-10-01546" ref-type="bibr">34</xref>]</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2001</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wheat Germ Extract Decreases Glucose Uptake and RNA<break/>Ribose Formation but Increases Fatty Acid Synthesis in MIA<break/>Pancreatic Adenocarcinoma Cells.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MIA pancreatic adenocarcinoma cells.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Evaluation of glucose utilization rates and lactate production.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Regulation of tumor cell proliferation.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibitory effect on glucose consumption, little effect on lactate production.</td></tr></tbody></table><table-wrap-foot><p>PARP: poly ADP ribose polymerase, ATP: Adenosine triphosphate, G6PDH: Glucose-6-phosphate dehydrogenase, LDH: Lactate dehydrogenase, NADH: reduced Nicotinamide adenine dinucleotide; NAD+: oxidized nicotinamide adenine dinucleotide; HK: Hexokinase, 5-FdUrd/ara-C: 5-fluorodeoxyuridine/cytosine arabinoside; HeLa: human cervical carcinoma, RT-qPCR: Total RNA isolation and reverse transcription-quantitative polymerase chain reaction, dNTPs: deoxyribonucleoside triphosphates; Cox-2: cyclooxygenase-2; VEGF: vascular endothelial growth factor; dNTPS: deoxyribonucleoside triphosphates.</p></table-wrap-foot></table-wrap></floats-group></article>